
    
      Study Objectives:

      Primary Objective

      â€¢ To evaluate the safety/tolerability of a single intravitreal (IVT) dose of BFC-1401 in
      participants as a vitreous substitute during vitrectomy surgery.

      Secondary Objective

        -  To assess retinal attachment and hydrogel degradation at Day 120.

        -  To assess best corrected visual acuity (BCVA) after vitrectomy surgery.
    
  